Pfizer deal paves way for approval of ImaginAb’s cancer imaging techImaginAb has signed a deal with Pfizer, which it hopes will help it to gather information necessary for Share XPfizer deal paves way for approval of ImaginAb’s cancer imaging techhttps://pharmaphorum.com/news/pfizer-deal-could-help-approval-of-imaginabs-cancer-imaging-tech/
Health strategy consultancy CREATION.co makes two senior hiresHealth strategy consultancy CREATION.co has made two senior appointments, with former government analyst Tom Bourne and former TV Share XHealth strategy consultancy CREATION.co makes two senior hireshttps://pharmaphorum.com/news/health-strategy-consultancy-creation-co-makes-two-senior-hires/
High hopes as Inventiva takes NASH contender into phase 3Analysts are continuing to back Inventiva’s lanifibranor as a potential “best-in-class” drug for the fatty liver disease NASH, Share XHigh hopes as Inventiva takes NASH contender into phase 3https://pharmaphorum.com/news/high-hopes-as-inventiva-takes-nash-contender-into-phase-3/
Pfizer drops the blue pill, kicks off 2021 with new DNA logoPharma companies are always talking about moving ‘beyond the pill’, and Pfizer’s new brand identity embodies that – Share XPfizer drops the blue pill, kicks off 2021 with new DNA logohttps://pharmaphorum.com/news/pfizer-drops-the-blue-pill-kicks-off-2021-with-new-dna-logo/
UK promises ‘uplift’ in COVID-19 vaccinations as crisis deepensThe UK government has promised a “massive uplift” in the number of coronavirus vaccinations carried out this week, Share XUK promises ‘uplift’ in COVID-19 vaccinations as crisis deepenshttps://pharmaphorum.com/news/uk-promises-uplift-in-covid-vaccinations-as-crisis-deepens/
Novo Nordisk’s gene silencing alliance with Dicerna bears first fruitTwo years after starting to work together, Novo Nordisk and Dicerna have selected the first candidate from a Share XNovo Nordisk’s gene silencing alliance with Dicerna bears first fruithttps://pharmaphorum.com/news/novo-nordisks-gene-silencing-alliance-with-dicerna-bears-first-fruit/
NHS Digital awards £8m COVID record contract to X-labThe UK government agency NHS Digital has awarded an £8m digital system that processes coronavirus test results to Share XNHS Digital awards £8m COVID record contract to X-labhttps://pharmaphorum.com/news/nhs-digital-awards-8m-covid-record-contract-to-x-lab/
Ex-Resolute co-founder Blackburn starts hybrid agency Certain HealthFormer joint founder and owner of Resolute Communications and Real Science Paul Blackburn has launched a new hybrid Share XEx-Resolute co-founder Blackburn starts hybrid agency Certain Healthhttps://pharmaphorum.com/news/ex-resolute-co-founder-blackburn-starts-hybrid-agency-certain-health/
Clene goes public with gold-based neurology nanotechnologyBiotech Clene Nanomedicine has gone public with a mission to use nanotherapeutics that will use gold to treat Share XClene goes public with gold-based neurology nanotechnologyhttps://pharmaphorum.com/news/clene-goes-public-with-gold-based-neurology-nanotechnology/
